Aptevo Therapeutics Inc.·4

Jul 19, 4:34 PM ET

White Marvin L 4

4 · Aptevo Therapeutics Inc. · Filed Jul 19, 2024

Insider Transaction Report

Form 4
Period: 2024-07-17
White Marvin L
DirectorPresident and CEO
Transactions
  • Award

    Restricted Stock Unit

    2024-07-17+22,32522,325 total
    Common Stock (22,325 underlying)
Footnotes (2)
  • [F1]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
  • [F2]The RSUs vest in three approximately equal annual installments beginning on June 17, 2025.

Documents

1 file
  • 4
    ownership.xmlPrimary

    4